Biotechnology Stocks I Performance Guide: United Therapeutics Corporation (UTHR)
UTHR has no dividends
Table and Chart of UTHR Performance
See what a $1,000 investment in UTHR is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| UTHR Returns | |
|---|---|
| Start Date | Dec-31-2013 |
| Start Price | $113.08 |
| End Date | Dec-01-2023 |
| End Price | $240.73 |
| # Prices | 121 |
| Min Date | Jun-28-2019 |
| Min Price | $78.06 |
| Max Date | Nov-30-2022 |
| Max Price | $279.89 |
| Total Return | 112.88% |
| Annualized Return | 7.78% |
| Current Value of $1,000 Purchase | $2,129 |
| Number Returns | 7,260 |
| Average Return | 35.05% |
| Number Profitable Returns | 4,915 |
| Percent Profitable Returns | 67.70% |
| Number Unprofitable Returns | 2,345 |
| Percent Unprofitable Returns | 32.30% |
| Profitable to Unprofitable Returns Ratio | 2.10 |
| UTHR Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $11,312,769,000 | Price to Sales | 5.13 |
| Earnings per Share | $18.1400 |
| PE Ratio | 13.27 |
| PE to Growth Ratio | 1.516 |
| Price to Book | 1.982 |
| PRICE DATA | |
| 52 Week High | $283.09 |
| 52 Week Low | $204.44 |
| Analyst Target Price | $286.96 |
| 50-Day Moving Average | $228.09 |
| 200-Day Moving Average | $227.4 |
| FINANCIAL DATA | |
| Revenue per Share | $47.35 |
| Revenue | $2,204,300,000 |
| Profit Margin | 40.8% |
| Return on Equity | 0.175% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
UTHR Compare Returns with S&P 500
UTHR Trendline Chart